320 related articles for article (PubMed ID: 19822810)
1. Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome.
Levin MA; Lin HM; Castillo JG; Adams DH; Reich DL; Fischer GW
Circulation; 2009 Oct; 120(17):1664-71. PubMed ID: 19822810
[TBL] [Abstract][Full Text] [Related]
2. A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery.
Noto A; Lentini S; Versaci A; Giardina M; Risitano DC; Messina R; David A
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):588-92. PubMed ID: 19581293
[TBL] [Abstract][Full Text] [Related]
3. Use of partial cardiopulmonary bypass for coarctation repair through a left thoracotomy in children without collaterals.
Backer CL; Stewart RD; Kelle AM; Mavroudis C
Ann Thorac Surg; 2006 Sep; 82(3):964-72. PubMed ID: 16928517
[TBL] [Abstract][Full Text] [Related]
4. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery.
Ozal E; Kuralay E; Yildirim V; Kilic S; Bolcal C; Kücükarslan N; Günay C; Demirkilic U; Tatar H
Ann Thorac Surg; 2005 May; 79(5):1615-9. PubMed ID: 15854942
[TBL] [Abstract][Full Text] [Related]
5. Cardiopulmonary bypass management and acute renal failure: risk factors and prognosis.
Sirvinskas E; Andrejaitiene J; Raliene L; Nasvytis L; Karbonskiene A; Pilvinis V; Sakalauskas J
Perfusion; 2008 Nov; 23(6):323-7. PubMed ID: 19454560
[TBL] [Abstract][Full Text] [Related]
6. Effect of mean arterial pressure, haemoglobin and blood transfusion during cardiopulmonary bypass on post-operative acute kidney injury.
Haase M; Bellomo R; Story D; Letis A; Klemz K; Matalanis G; Seevanayagam S; Dragun D; Seeliger E; Mertens PR; Haase-Fielitz A
Nephrol Dial Transplant; 2012 Jan; 27(1):153-60. PubMed ID: 21677302
[TBL] [Abstract][Full Text] [Related]
7. Miniaturized cardiopulmonary bypass and acute kidney injury in coronary artery bypass graft surgery.
Benedetto U; Luciani R; Goracci M; Capuano F; Refice S; Angeloni E; Roscitano A; Sinatra R
Ann Thorac Surg; 2009 Aug; 88(2):529-35. PubMed ID: 19632407
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for prolonged ICU stay in patients following coronary artery bypass grafting with a long duration of cardiopulmonary bypass.
Nakasuji M; Matsushita M; Asada A
J Anesth; 2005; 19(2):118-23. PubMed ID: 15875128
[TBL] [Abstract][Full Text] [Related]
9. Role of endogenous adenosine as a predictive marker of vasoplegia during cardiopulmonary bypass and postoperative severe systemic inflammatory response.
Kerbaul F; Collart F; Giorgi R; Ibrahim Z; Guillen JC; Gil JM; Saadjian A; Mouly-Bandini A; Habib G; Gouin F; Guieu R
Crit Care Med; 2006 Mar; 34(3):640-5. PubMed ID: 16505647
[TBL] [Abstract][Full Text] [Related]
10. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
[TBL] [Abstract][Full Text] [Related]
11. Case control study of gastrointestinal complications after cardiopulmonary bypass heart surgery.
Zhang G; Wu N; Liu H; Lv H; Yao Z; Li J
Perfusion; 2009 May; 24(3):173-8. PubMed ID: 19755467
[TBL] [Abstract][Full Text] [Related]
12. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE
Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
[TBL] [Abstract][Full Text] [Related]
13. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery.
Salis S; Mazzanti VV; Merli G; Salvi L; Tedesco CC; Veglia F; Sisillo E
J Cardiothorac Vasc Anesth; 2008 Dec; 22(6):814-22. PubMed ID: 18948034
[TBL] [Abstract][Full Text] [Related]
14. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
Levin RL; Degrange MA; Bruno GF; Del Mazo CD; Taborda DJ; Griotti JJ; Boullon FJ
Ann Thorac Surg; 2004 Feb; 77(2):496-9. PubMed ID: 14759425
[TBL] [Abstract][Full Text] [Related]
15. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
Kincaid EH; Ashburn DA; Hoyle JR; Reichert MG; Hammon JW; Kon ND
Ann Thorac Surg; 2005 Oct; 80(4):1388-93; discussion 1393. PubMed ID: 16181876
[TBL] [Abstract][Full Text] [Related]
16. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
Manrique A; Jooste EH; Kuch BA; Lichtenstein SE; Morell V; Munoz R; Ellis D; Davis PJ
Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694
[TBL] [Abstract][Full Text] [Related]
17. Open-heart surgery in patients with liver cirrhosis: indications, risk factors, and clinical outcomes.
An Y; Xiao YB; Zhong QJ
Eur Surg Res; 2007; 39(2):67-74. PubMed ID: 17283429
[TBL] [Abstract][Full Text] [Related]
18. Coronary bypass surgery performed off pump does not result in lower in-hospital morbidity than coronary artery bypass grafting performed on pump.
Légaré JF; Buth KJ; King S; Wood J; Sullivan JA; Hancock Friesen C; Lee J; Stewart K; Hirsch GM
Circulation; 2004 Feb; 109(7):887-92. PubMed ID: 14757693
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass.
Pretorius M; Donahue BS; Yu C; Greelish JP; Roden DM; Brown NJ
Circulation; 2007 Sep; 116(11 Suppl):I1-7. PubMed ID: 17846288
[TBL] [Abstract][Full Text] [Related]
20. Vasoplegia during cardiac surgery: current concepts and management.
Fischer GW; Levin MA
Semin Thorac Cardiovasc Surg; 2010; 22(2):140-4. PubMed ID: 21092891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
